GLPG0974

GLPG0974
Identifiers
  • 4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC25H25ClN2O4S
Molar mass485.00 g·mol−1
3D model (JSmol)
  • C[C@@]1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl
  • InChI=1S/C21H21ClN2OS/c1-21(2,3)18(15-9-11-16(22)12-10-15)19(25)24-20-23-13-17(26-20)14-7-5-4-6-8-14/h4-13,18H,1-3H3,(H,23,24,25)/t18-/m0/s1
  • Key:MPMKMQHJHDHPBE-RUZDIDTESA-N

GLPG0974 is an experimental drug which acts as a reasonably potent and selective antagonist for the free fatty acid receptor FFAR2 (GPR43). It was originally developed as a potential medication for ulcerative colitis, and while it was not developed as a medicine for this application it has remained widely used as a pharmacological tool compound for research into the FFAR2 receptor, as one of the relatively few selective FFAR2 antagonists available.[1][2][3][4][5] Despite its antagonist action, it can also act as a positive allosteric modulator of FFAR2 under some conditions, which can complicate interpretation of results obtained using GLPG0974 in the presence of other FFAR2 ligands.[6]

References

  1. ^ Pizzonero M, Dupont S, Babel M, Beaumont S, Bienvenu N, Blanqué R, et al. (December 2014). "Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic". Journal of Medicinal Chemistry. 57 (23): 10044–10057. doi:10.1021/jm5012885. PMID 25380412.
  2. ^ Namour F, Galien R, Van Kaem T, Van der Aa A, Vanhoutte F, Beetens J, et al. (July 2016). "Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects". British Journal of Clinical Pharmacology. 82 (1): 139–148. doi:10.1111/bcp.12900. PMC 4917808. PMID 26852904.
  3. ^ Akiba Y, Maruta K, Narimatsu K, Said H, Kaji I, Kuri A, et al. (August 2017). "FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats". American Journal of Physiology. Gastrointestinal and Liver Physiology. 313 (2): G117–G128. doi:10.1152/ajpgi.00041.2017. PMC 5582879. PMID 28526687.
  4. ^ Miyasato S, Iwata K, Mura R, Nakamura S, Yanagida K, Shindou H, et al. (January 2023). "Constitutively active GPR43 is crucial for proper leukocyte differentiation". FASEB Journal. 37 (1): e22676. doi:10.1096/fj.202201591R. PMID 36468834.
  5. ^ Kugawa M, Kawakami K, Kise R, Suomivuori CM, Tsujimura M, Kobayashi K, et al. (March 2025). "Structural insights into lipid chain-length selectivity and allosteric regulation of FFA2". Nature Communications. 16 (1) 2809. Bibcode:2025NatCo..16.2809K. doi:10.1038/s41467-025-57983-4. PMC 11947310. PMID 40140663.
  6. ^ Lind S, Hoffmann DO, Forsman H, Dahlgren C (February 2022). "Allosteric receptor modulation uncovers an FFA2R antagonist as a positive orthosteric modulator/agonist in disguise". Cellular Signalling. 90 110208. doi:10.1016/j.cellsig.2021.110208. PMID 34856356.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.